カテゴリー： 世界, 医療/バイオ, QYResearch

シングルセルマルチオミクスの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Single Cell Multiomics Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09285）・商品コード：QY22JLX09285
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、シングルセルマルチオミクスのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシングルセルマルチオミクスの世界市場のxxx％を占める「シングルセル＆ゲノミクス」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腫瘍」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
シングルセルマルチオミクスの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのシングルセルマルチオミクス市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

シングルセルマルチオミクスのグローバル主要企業には、10x Genomics、Becton, Dickinson and Company、Berkeley Lights、BGI Genomics、Bio Rad Laboratories、Danaher Corporation (Cytiva Life Sciences)、Dolomite Bio、Epicypher、Fluidigm Corporation、Illimina、Miltenyi Biotec B.V. & CO.、Mission Bio、Nanostring Technologies、Olink Holding AB (Olink Proteomics)、Parse Bioscience、Qiagen N.V.、Takara Holdings Inc. Takara Bio Group、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

シングルセルマルチオミクス市場は、種類と用途によって区分されます。世界のシングルセルマルチオミクス市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
シングルセル＆ゲノミクス、シングルセル＆プロテオミクス、シングルセル＆トランスクリプトミクス、シングルセル＆メタボロミクス

【用途別セグメント】
腫瘍、細胞生物、神経、免疫、幹細胞研究

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- シングルセルマルチオミクス製品概要
- 種類別市場（シングルセル＆ゲノミクス、シングルセル＆プロテオミクス、シングルセル＆トランスクリプトミクス、シングルセル＆メタボロミクス）
- 用途別市場（腫瘍、細胞生物、神経、免疫、幹細胞研究）
- 調査の目的
・エグゼクティブサマリー
- 世界のシングルセルマルチオミクス販売量予測2017-2028
- 世界のシングルセルマルチオミクス売上予測2017-2028
- シングルセルマルチオミクスの地域別販売量
- シングルセルマルチオミクスの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別シングルセルマルチオミクス販売量
- 主要メーカー別シングルセルマルチオミクス売上
- 主要メーカー別シングルセルマルチオミクス価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（シングルセル＆ゲノミクス、シングルセル＆プロテオミクス、シングルセル＆トランスクリプトミクス、シングルセル＆メタボロミクス）
- シングルセルマルチオミクスの種類別販売量
- シングルセルマルチオミクスの種類別売上
- シングルセルマルチオミクスの種類別価格
・用途別市場規模（腫瘍、細胞生物、神経、免疫、幹細胞研究）
- シングルセルマルチオミクスの用途別販売量
- シングルセルマルチオミクスの用途別売上
- シングルセルマルチオミクスの用途別価格
・北米市場
- 北米のシングルセルマルチオミクス市場規模（種類別、用途別）
- 主要国別のシングルセルマルチオミクス市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのシングルセルマルチオミクス市場規模（種類別、用途別）
- 主要国別のシングルセルマルチオミクス市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のシングルセルマルチオミクス市場規模（種類別、用途別）
- 主要国別のシングルセルマルチオミクス市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のシングルセルマルチオミクス市場規模（種類別、用途別）
- 主要国別のシングルセルマルチオミクス市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのシングルセルマルチオミクス市場規模（種類別、用途別）
- 主要国別のシングルセルマルチオミクス市場規模（トルコ、サウジアラビア）
・企業情報
10x Genomics、Becton, Dickinson and Company、Berkeley Lights、BGI Genomics、Bio Rad Laboratories、Danaher Corporation (Cytiva Life Sciences)、Dolomite Bio、Epicypher、Fluidigm Corporation、Illimina、Miltenyi Biotec B.V. & CO.、Mission Bio、Nanostring Technologies、Olink Holding AB (Olink Proteomics)、Parse Bioscience、Qiagen N.V.、Takara Holdings Inc. Takara Bio Group、Thermo Fisher Scientific
・産業チェーン及び販売チャネル分析
- シングルセルマルチオミクスの産業チェーン分析
- シングルセルマルチオミクスの原材料
- シングルセルマルチオミクスの生産プロセス
- シングルセルマルチオミクスの販売及びマーケティング
- シングルセルマルチオミクスの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- シングルセルマルチオミクスの産業動向
- シングルセルマルチオミクスのマーケットドライバー
- シングルセルマルチオミクスの課題
- シングルセルマルチオミクスの阻害要因
・主な調査結果

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Market Analysis and Insights: Global Single Cell Multiomics Market
The global Single Cell Multiomics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, by Type accounting for % of the Single Cell Multiomics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Single Cell Multiomics market size is valued at US$ million in 2021, while the North America and Europe Single Cell Multiomics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Single Cell Multiomics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Single Cell Multiomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Single Cell Multiomics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Single Cell Multiomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Single Cell Multiomics market.
Global Single Cell Multiomics Scope and Market Size
Single Cell Multiomics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Single Cell Multiomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
by Type
Single cell genomics
Single cell proteomics
Single cell transcriptomics
Single cell metabolomics
by Technique
Single cell isolation and dispensing
Single cell analysis
Segment by Application
Oncology
Cell biology
Neurology
Immunology
Stem cell research
By Company
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Multiomics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single cell genomics
1.2.3 Single cell proteomics
1.2.4 Single cell transcriptomics
1.2.5 Single cell metabolomics
1.3 Market by Application
1.3.1 Global Single Cell Multiomics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cell biology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Stem cell research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Multiomics Market Perspective (2017-2028)
2.2 Single Cell Multiomics Growth Trends by Region
2.2.1 Single Cell Multiomics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Single Cell Multiomics Historic Market Size by Region (2017-2022)
2.2.3 Single Cell Multiomics Forecasted Market Size by Region (2023-2028)
2.3 Single Cell Multiomics Market Dynamics
2.3.1 Single Cell Multiomics Industry Trends
2.3.2 Single Cell Multiomics Market Drivers
2.3.3 Single Cell Multiomics Market Challenges
2.3.4 Single Cell Multiomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Multiomics Players by Revenue
3.1.1 Global Top Single Cell Multiomics Players by Revenue (2017-2022)
3.1.2 Global Single Cell Multiomics Revenue Market Share by Players (2017-2022)
3.2 Global Single Cell Multiomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell Multiomics Revenue
3.4 Global Single Cell Multiomics Market Concentration Ratio
3.4.1 Global Single Cell Multiomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Multiomics Revenue in 2021
3.5 Single Cell Multiomics Key Players Head office and Area Served
3.6 Key Players Single Cell Multiomics Product Solution and Service
3.7 Date of Enter into Single Cell Multiomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell Multiomics Breakdown Data by Type
4.1 Global Single Cell Multiomics Historic Market Size by Type (2017-2022)
4.2 Global Single Cell Multiomics Forecasted Market Size by Type (2023-2028)
5 Single Cell Multiomics Breakdown Data by Application
5.1 Global Single Cell Multiomics Historic Market Size by Application (2017-2022)
5.2 Global Single Cell Multiomics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Single Cell Multiomics Market Size (2017-2028)
6.2 North America Single Cell Multiomics Market Size by Type
6.2.1 North America Single Cell Multiomics Market Size by Type (2017-2022)
6.2.2 North America Single Cell Multiomics Market Size by Type (2023-2028)
6.2.3 North America Single Cell Multiomics Market Share by Type (2017-2028)
6.3 North America Single Cell Multiomics Market Size by Application
6.3.1 North America Single Cell Multiomics Market Size by Application (2017-2022)
6.3.2 North America Single Cell Multiomics Market Size by Application (2023-2028)
6.3.3 North America Single Cell Multiomics Market Share by Application (2017-2028)
6.4 North America Single Cell Multiomics Market Size by Country
6.4.1 North America Single Cell Multiomics Market Size by Country (2017-2022)
6.4.2 North America Single Cell Multiomics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Single Cell Multiomics Market Size (2017-2028)
7.2 Europe Single Cell Multiomics Market Size by Type
7.2.1 Europe Single Cell Multiomics Market Size by Type (2017-2022)
7.2.2 Europe Single Cell Multiomics Market Size by Type (2023-2028)
7.2.3 Europe Single Cell Multiomics Market Share by Type (2017-2028)
7.3 Europe Single Cell Multiomics Market Size by Application
7.3.1 Europe Single Cell Multiomics Market Size by Application (2017-2022)
7.3.2 Europe Single Cell Multiomics Market Size by Application (2023-2028)
7.3.3 Europe Single Cell Multiomics Market Share by Application (2017-2028)
7.4 Europe Single Cell Multiomics Market Size by Country
7.4.1 Europe Single Cell Multiomics Market Size by Country (2017-2022)
7.4.2 Europe Single Cell Multiomics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Multiomics Market Size (2017-2028)
8.2 Asia-Pacific Single Cell Multiomics Market Size by Type
8.2.1 Asia-Pacific Single Cell Multiomics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Single Cell Multiomics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Single Cell Multiomics Market Share by Type (2017-2028)
8.3 Asia-Pacific Single Cell Multiomics Market Size by Application
8.3.1 Asia-Pacific Single Cell Multiomics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Single Cell Multiomics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Single Cell Multiomics Market Share by Application (2017-2028)
8.4 Asia-Pacific Single Cell Multiomics Market Size by Region
8.4.1 Asia-Pacific Single Cell Multiomics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Single Cell Multiomics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Single Cell Multiomics Market Size (2017-2028)
9.2 Latin America Single Cell Multiomics Market Size by Type
9.2.1 Latin America Single Cell Multiomics Market Size by Type (2017-2022)
9.2.2 Latin America Single Cell Multiomics Market Size by Type (2023-2028)
9.2.3 Latin America Single Cell Multiomics Market Share by Type (2017-2028)
9.3 Latin America Single Cell Multiomics Market Size by Application
9.3.1 Latin America Single Cell Multiomics Market Size by Application (2017-2022)
9.3.2 Latin America Single Cell Multiomics Market Size by Application (2023-2028)
9.3.3 Latin America Single Cell Multiomics Market Share by Application (2017-2028)
9.4 Latin America Single Cell Multiomics Market Size by Country
9.4.1 Latin America Single Cell Multiomics Market Size by Country (2017-2022)
9.4.2 Latin America Single Cell Multiomics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Multiomics Market Size (2017-2028)
10.2 Middle East & Africa Single Cell Multiomics Market Size by Type
10.2.1 Middle East & Africa Single Cell Multiomics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Single Cell Multiomics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Single Cell Multiomics Market Share by Type (2017-2028)
10.3 Middle East & Africa Single Cell Multiomics Market Size by Application
10.3.1 Middle East & Africa Single Cell Multiomics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Single Cell Multiomics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Single Cell Multiomics Market Share by Application (2017-2028)
10.4 Middle East & Africa Single Cell Multiomics Market Size by Country
10.4.1 Middle East & Africa Single Cell Multiomics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Single Cell Multiomics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Details
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Single Cell Multiomics Introduction
11.1.4 10x Genomics Revenue in Single Cell Multiomics Business (2017-2022)
11.1.5 10x Genomics Recent Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Single Cell Multiomics Introduction
11.2.4 Becton, Dickinson and Company Revenue in Single Cell Multiomics Business (2017-2022)
11.2.5 Becton, Dickinson and Company Recent Developments
11.3 Berkeley Lights
11.3.1 Berkeley Lights Company Details
11.3.2 Berkeley Lights Business Overview
11.3.3 Berkeley Lights Single Cell Multiomics Introduction
11.3.4 Berkeley Lights Revenue in Single Cell Multiomics Business (2017-2022)
11.3.5 Berkeley Lights Recent Developments
11.4 BGI Genomics
11.4.1 BGI Genomics Company Details
11.4.2 BGI Genomics Business Overview
11.4.3 BGI Genomics Single Cell Multiomics Introduction
11.4.4 BGI Genomics Revenue in Single Cell Multiomics Business (2017-2022)
11.4.5 BGI Genomics Recent Developments
11.5 Bio Rad Laboratories
11.5.1 Bio Rad Laboratories Company Details
11.5.2 Bio Rad Laboratories Business Overview
11.5.3 Bio Rad Laboratories Single Cell Multiomics Introduction
11.5.4 Bio Rad Laboratories Revenue in Single Cell Multiomics Business (2017-2022)
11.5.5 Bio Rad Laboratories Recent Developments
11.6 Danaher Corporation (Cytiva Life Sciences)
11.6.1 Danaher Corporation (Cytiva Life Sciences) Company Details
11.6.2 Danaher Corporation (Cytiva Life Sciences) Business Overview
11.6.3 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Introduction
11.6.4 Danaher Corporation (Cytiva Life Sciences) Revenue in Single Cell Multiomics Business (2017-2022)
11.6.5 Danaher Corporation (Cytiva Life Sciences) Recent Developments
11.7 Dolomite Bio
11.7.1 Dolomite Bio Company Details
11.7.2 Dolomite Bio Business Overview
11.7.3 Dolomite Bio Single Cell Multiomics Introduction
11.7.4 Dolomite Bio Revenue in Single Cell Multiomics Business (2017-2022)
11.7.5 Dolomite Bio Recent Developments
11.8 Epicypher
11.8.1 Epicypher Company Details
11.8.2 Epicypher Business Overview
11.8.3 Epicypher Single Cell Multiomics Introduction
11.8.4 Epicypher Revenue in Single Cell Multiomics Business (2017-2022)
11.8.5 Epicypher Recent Developments
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Details
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation Single Cell Multiomics Introduction
11.9.4 Fluidigm Corporation Revenue in Single Cell Multiomics Business (2017-2022)
11.9.5 Fluidigm Corporation Recent Developments
11.10 Illimina
11.10.1 Illimina Company Details
11.10.2 Illimina Business Overview
11.10.3 Illimina Single Cell Multiomics Introduction
11.10.4 Illimina Revenue in Single Cell Multiomics Business (2017-2022)
11.10.5 Illimina Recent Developments
11.11 Miltenyi Biotec B.V. & CO.
11.11.1 Miltenyi Biotec B.V. & CO. Company Details
11.11.2 Miltenyi Biotec B.V. & CO. Business Overview
11.11.3 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Introduction
11.11.4 Miltenyi Biotec B.V. & CO. Revenue in Single Cell Multiomics Business (2017-2022)
11.11.5 Miltenyi Biotec B.V. & CO. Recent Developments
11.12 Mission Bio
11.12.1 Mission Bio Company Details
11.12.2 Mission Bio Business Overview
11.12.3 Mission Bio Single Cell Multiomics Introduction
11.12.4 Mission Bio Revenue in Single Cell Multiomics Business (2017-2022)
11.12.5 Mission Bio Recent Developments
11.13 Nanostring Technologies
11.13.1 Nanostring Technologies Company Details
11.13.2 Nanostring Technologies Business Overview
11.13.3 Nanostring Technologies Single Cell Multiomics Introduction
11.13.4 Nanostring Technologies Revenue in Single Cell Multiomics Business (2017-2022)
11.13.5 Nanostring Technologies Recent Developments
11.14 Olink Holding AB (Olink Proteomics)
11.14.1 Olink Holding AB (Olink Proteomics) Company Details
11.14.2 Olink Holding AB (Olink Proteomics) Business Overview
11.14.3 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Introduction
11.14.4 Olink Holding AB (Olink Proteomics) Revenue in Single Cell Multiomics Business (2017-2022)
11.14.5 Olink Holding AB (Olink Proteomics) Recent Developments
11.15 Parse Bioscience
11.15.1 Parse Bioscience Company Details
11.15.2 Parse Bioscience Business Overview
11.15.3 Parse Bioscience Single Cell Multiomics Introduction
11.15.4 Parse Bioscience Revenue in Single Cell Multiomics Business (2017-2022)
11.15.5 Parse Bioscience Recent Developments
11.16 Qiagen N.V.
11.16.1 Qiagen N.V. Company Details
11.16.2 Qiagen N.V. Business Overview
11.16.3 Qiagen N.V. Single Cell Multiomics Introduction
11.16.4 Qiagen N.V. Revenue in Single Cell Multiomics Business (2017-2022)
11.16.5 Qiagen N.V. Recent Developments
11.17 Takara Holdings Inc. Takara Bio Group
11.17.1 Takara Holdings Inc. Takara Bio Group Company Details
11.17.2 Takara Holdings Inc. Takara Bio Group Business Overview
11.17.3 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Introduction
11.17.4 Takara Holdings Inc. Takara Bio Group Revenue in Single Cell Multiomics Business (2017-2022)
11.17.5 Takara Holdings Inc. Takara Bio Group Recent Developments
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Details
11.18.2 Thermo Fisher Scientific Business Overview
11.18.3 Thermo Fisher Scientific Single Cell Multiomics Introduction
11.18.4 Thermo Fisher Scientific Revenue in Single Cell Multiomics Business (2017-2022)
11.18.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Single Cell Multiomics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Single cell genomics
Table 3. Key Players of Single cell proteomics
Table 4. Key Players of Single cell transcriptomics
Table 5. Key Players of Single cell metabolomics
Table 6. Global Single Cell Multiomics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Single Cell Multiomics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Single Cell Multiomics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Single Cell Multiomics Market Share by Region (2017-2022)
Table 10. Global Single Cell Multiomics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Single Cell Multiomics Market Share by Region (2023-2028)
Table 12. Single Cell Multiomics Market Trends
Table 13. Single Cell Multiomics Market Drivers
Table 14. Single Cell Multiomics Market Challenges
Table 15. Single Cell Multiomics Market Restraints
Table 16. Global Single Cell Multiomics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Single Cell Multiomics Revenue Share by Players (2017-2022)
Table 18. Global Top Single Cell Multiomics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2021)
Table 19. Ranking of Global Top Single Cell Multiomics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Single Cell Multiomics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Single Cell Multiomics Product Solution and Service
Table 23. Date of Enter into Single Cell Multiomics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Single Cell Multiomics Revenue Market Share by Type (2017-2022)
Table 27. Global Single Cell Multiomics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Single Cell Multiomics Revenue Market Share by Type (2023-2028)
Table 29. Global Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Single Cell Multiomics Revenue Share by Application (2017-2022)
Table 31. Global Single Cell Multiomics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Single Cell Multiomics Revenue Share by Application (2023-2028)
Table 33. North America Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Single Cell Multiomics Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Single Cell Multiomics Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Single Cell Multiomics Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Single Cell Multiomics Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Single Cell Multiomics Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Single Cell Multiomics Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Single Cell Multiomics Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Single Cell Multiomics Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Single Cell Multiomics Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Single Cell Multiomics Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Single Cell Multiomics Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Single Cell Multiomics Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Single Cell Multiomics Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Single Cell Multiomics Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Single Cell Multiomics Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Single Cell Multiomics Market Size by Country (2023-2028) & (US$ Million)
Table 63. 10x Genomics Company Details
Table 64. 10x Genomics Business Overview
Table 65. 10x Genomics Single Cell Multiomics Product
Table 66. 10x Genomics Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 67. 10x Genomics Recent Developments
Table 68. Becton, Dickinson and Company Company Details
Table 69. Becton, Dickinson and Company Business Overview
Table 70. Becton, Dickinson and Company Single Cell Multiomics Product
Table 71. Becton, Dickinson and Company Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 72. Becton, Dickinson and Company Recent Developments
Table 73. Berkeley Lights Company Details
Table 74. Berkeley Lights Business Overview
Table 75. Berkeley Lights Single Cell Multiomics Product
Table 76. Berkeley Lights Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 77. Berkeley Lights Recent Developments
Table 78. BGI Genomics Company Details
Table 79. BGI Genomics Business Overview
Table 80. BGI Genomics Single Cell Multiomics Product
Table 81. BGI Genomics Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 82. BGI Genomics Recent Developments
Table 83. Bio Rad Laboratories Company Details
Table 84. Bio Rad Laboratories Business Overview
Table 85. Bio Rad Laboratories Single Cell Multiomics Product
Table 86. Bio Rad Laboratories Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 87. Bio Rad Laboratories Recent Developments
Table 88. Danaher Corporation (Cytiva Life Sciences) Company Details
Table 89. Danaher Corporation (Cytiva Life Sciences) Business Overview
Table 90. Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Product
Table 91. Danaher Corporation (Cytiva Life Sciences) Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 92. Danaher Corporation (Cytiva Life Sciences) Recent Developments
Table 93. Dolomite Bio Company Details
Table 94. Dolomite Bio Business Overview
Table 95. Dolomite Bio Single Cell Multiomics Product
Table 96. Dolomite Bio Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 97. Dolomite Bio Recent Developments
Table 98. Epicypher Company Details
Table 99. Epicypher Business Overview
Table 100. Epicypher Single Cell Multiomics Product
Table 101. Epicypher Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 102. Epicypher Recent Developments
Table 103. Fluidigm Corporation Company Details
Table 104. Fluidigm Corporation Business Overview
Table 105. Fluidigm Corporation Single Cell Multiomics Product
Table 106. Fluidigm Corporation Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 107. Fluidigm Corporation Recent Developments
Table 108. Illimina Company Details
Table 109. Illimina Business Overview
Table 110. Illimina Single Cell Multiomics Product
Table 111. Illimina Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 112. Illimina Recent Developments
Table 113. Miltenyi Biotec B.V. & CO. Company Details
Table 114. Miltenyi Biotec B.V. & CO. Business Overview
Table 115. Miltenyi Biotec B.V. & CO. Single Cell Multiomics Product
Table 116. Miltenyi Biotec B.V. & CO. Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 117. Miltenyi Biotec B.V. & CO. Recent Developments
Table 118. Mission Bio Company Details
Table 119. Mission Bio Business Overview
Table 120. Mission Bio Single Cell Multiomics Product
Table 121. Mission Bio Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 122. Mission Bio Recent Developments
Table 123. Nanostring Technologies Company Details
Table 124. Nanostring Technologies Business Overview
Table 125. Nanostring Technologies Single Cell Multiomics Product
Table 126. Nanostring Technologies Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 127. Nanostring Technologies Recent Developments
Table 128. Olink Holding AB (Olink Proteomics) Company Details
Table 129. Olink Holding AB (Olink Proteomics) Business Overview
Table 130. Olink Holding AB (Olink Proteomics) Single Cell Multiomics Product
Table 131. Olink Holding AB (Olink Proteomics) Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 132. Olink Holding AB (Olink Proteomics) Recent Developments
Table 133. Parse Bioscience Company Details
Table 134. Parse Bioscience Business Overview
Table 135. Parse Bioscience Single Cell Multiomics Product
Table 136. Parse Bioscience Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 137. Parse Bioscience Recent Developments
Table 138. Qiagen N.V. Company Details
Table 139. Qiagen N.V. Business Overview
Table 140. Qiagen N.V. Single Cell Multiomics Product
Table 141. Qiagen N.V. Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 142. Qiagen N.V. Recent Developments
Table 143. Takara Holdings Inc. Takara Bio Group Company Details
Table 144. Takara Holdings Inc. Takara Bio Group Business Overview
Table 145. Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Product
Table 146. Takara Holdings Inc. Takara Bio Group Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 147. Takara Holdings Inc. Takara Bio Group Recent Developments
Table 148. Thermo Fisher Scientific Company Details
Table 149. Thermo Fisher Scientific Business Overview
Table 150. Thermo Fisher Scientific Single Cell Multiomics Product
Table 151. Thermo Fisher Scientific Revenue in Single Cell Multiomics Business (2017-2022) & (US$ Million)
Table 152. Thermo Fisher Scientific Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Single Cell Multiomics Market Share by Type: 2021 VS 2028
Figure 2. Single cell genomics Features
Figure 3. Single cell proteomics Features
Figure 4. Single cell transcriptomics Features
Figure 5. Single cell metabolomics Features
Figure 6. Global Single Cell Multiomics Market Share by Application: 2021 VS 2028
Figure 7. Oncology Case Studies
Figure 8. Cell biology Case Studies
Figure 9. Neurology Case Studies
Figure 10. Immunology Case Studies
Figure 11. Stem cell research Case Studies
Figure 12. Single Cell Multiomics Report Years Considered
Figure 13. Global Single Cell Multiomics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Single Cell Multiomics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Single Cell Multiomics Market Share by Region: 2021 VS 2028
Figure 16. Global Single Cell Multiomics Market Share by Players in 2021
Figure 17. Global Top Single Cell Multiomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Single Cell Multiomics Revenue in 2021
Figure 19. North America Single Cell Multiomics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Single Cell Multiomics Market Size Market Share by Type (2017-2028)
Figure 21. North America Single Cell Multiomics Market Size Market Share by Application (2017-2028)
Figure 22. North America Single Cell Multiomics Market Size Share by Country (2017-2028)
Figure 23. United States Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Single Cell Multiomics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Single Cell Multiomics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Single Cell Multiomics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Single Cell Multiomics Market Size Share by Country (2017-2028)
Figure 29. Germany Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Single Cell Multiomics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Single Cell Multiomics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Single Cell Multiomics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Single Cell Multiomics Market Size Share by Region (2017-2028)
Figure 39. China Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Single Cell Multiomics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Single Cell Multiomics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Single Cell Multiomics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Single Cell Multiomics Market Size Share by Country (2017-2028)
Figure 49. Mexico Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Single Cell Multiomics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Single Cell Multiomics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Single Cell Multiomics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Single Cell Multiomics Market Size Share by Country (2017-2028)
Figure 55. Turkey Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Single Cell Multiomics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. 10x Genomics Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 59. Becton, Dickinson and Company Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 60. Berkeley Lights Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 61. BGI Genomics Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 62. Bio Rad Laboratories Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 63. Danaher Corporation (Cytiva Life Sciences) Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 64. Dolomite Bio Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 65. Epicypher Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 66. Fluidigm Corporation Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 67. Illimina Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 68. Miltenyi Biotec B.V. & CO. Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 69. Mission Bio Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 70. Nanostring Technologies Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 71. Olink Holding AB (Olink Proteomics) Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 72. Parse Bioscience Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 73. Qiagen N.V. Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 74. Takara Holdings Inc. Takara Bio Group Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 75. Thermo Fisher Scientific Revenue Growth Rate in Single Cell Multiomics Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


★調査レポート[シングルセルマルチオミクスの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09285)販売に関する免責事項を必ずご確認ください。
★調査レポート[シングルセルマルチオミクスの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • シングルセルRNA配列の世界市場インサイト・予測（～2028年）
  • シングルセルディスペンサーの世界市場インサイト・予測（～2028年）
  • 昆虫細胞培地サプリメントの世界市場インサイト・予測（～2028年）
  • ウイルスワクチン細胞培養培地の世界市場インサイト・予測（～2028年）
  • 成体幹細胞保管の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆